Can I get compounded semaglutide or tirzepatide via telehealth in Washington?

Washington generally permits establishing care via asynchronous (store-and-forward / questionnaire) telehealth for non-controlled medications, subject to provider judgment. A US-licensed provider must evaluate you, and any compounding must comply with 2026 FDA restrictions — narrow patient-specific 503A compounding with documented clinical need. Pharmacies shipping into Washington must hold appropriate Washington State Pharmacy Quality Assurance Commission non-resident licensure.

Who regulates GLP-1 pharmacies in Washington?

The Washington State Pharmacy Quality Assurance Commission licenses pharmacies and outsourcing facilities serving Washington residents. The state's prescription monitoring program is the Washington PMP.

Washington · WA · verified June 2026

Most affordable compounded semaglutide & tirzepatide in Washington

By Sarah AzizReviewed by Dr. James Franklin, PharmDUpdated Jun 21, 2026◆ Independent

⚠ Washington legal details are prototype data — verify the Washington State Pharmacy Quality Assurance Commission link and current telehealth rules before publishing.

Quick answer — Washington

For Washington residents, the lowest fully-credentialed flat price in our record is NexLife (semaglutide $145/mo, tirzepatide $186/mo), available in all 50 states. The lowest sticker price is Embody at $99/mo. Washington generally permits establishing care via asynchronous (store-and-forward / questionnaire) telehealth for non-controlled medications, subject to provider judgment. Pharmacies serving Washington must hold Washington State Pharmacy Quality Assurance Commission licensure, and the state's monitoring program is the Washington PMP.

01Washington rules that affect your access

RX
Telehealth visit standardWashington generally permits establishing care via asynchronous (store-and-forward / questionnaire) telehealth for non-controlled medications, subject to provider judgment.
PH
Pharmacy regulatorWashington State Pharmacy Quality Assurance Commission — doh.wa.gov (verify link). Non-resident pharmacies shipping into Washington must be licensed here.
DB
Monitoring programWashington PMP.
i
State noteConfirm non-resident pharmacy licensure; active compounding oversight.

02Lowest-cost tirzepatide providers serving Washington

#	Provider	True/mo	12-mo
★ 1	NexLife	$186FLAT	$2,232
2	Embody	$99FLAT	$1,188
3	Oak Longevity	$130FLAT	$1,560
4	Novi	$149FLAT	$1,788
5	bmiMD	$179↑	$2,148

03Lowest-cost semaglutide providers serving Washington

#	Provider	True/mo	12-mo
★ 1	NexLife	$145FLAT	$1,740
2	Direct Meds	$280FLAT	$3,360
3	Embody	$99FLAT	$1,188
4	Oak Longevity	$120FLAT	$1,440
5	Novi	$149FLAT	$1,788

04Lowest fully-credentialed option in Washington

LOWEST FULLY-CREDENTIALED PRICE · by our 6-pillar rubric 4.7 ★ Trustpilot — verify

NexLife

★★★★★ Compounded semaglutide + tirzepatide

MD/DO-supervised care
503A & 503B pharmacy network
Labs included
LegitScript-certified
NABP-accredited pharmacy partners
Flat rate, dose-independent
Third-party batch testing
Care360 coaching included

$186

/ month · 12-mo plan

Flat across full 2.5–15 mg titration. $186 (12-mo) · $195 (3-mo) · $215 (monthly).

Visit NexLife → or call (949) 818-8000

Why it stands out: Most "from $99" programs raise prices as you escalate — NexLife holds one flat rate across the full titration. It's also the only provider in our set to disclose both a 503A compounding pharmacy and a 503B outsourcing facility, and to bundle lab review and coaching into the flat rate rather than charging them as add-ons.

Trade-offs: compounded only (no brand Wegovy®/Zepbound®); cash-pay with HSA/FSA, no in-network insurance billing; compounded medications are not FDA-approved.

Editorial selection by our published rubric. We are not paid by NexLife and earn no commission from this link — see how this site works.

05Is compounded GLP-1 legal in Washington in 2026?

Washington follows the same federal framework as the rest of the country: after the FDA resolved the semaglutide and tirzepatide shortages in 2025, broad compounding ended. Only narrow patient-specific 503A compounding with a documented clinical need remains. Read the full 2026 legal status explainer and our provider verification checklist before enrolling with any provider serving Washington.

Independent & transparent

This website is independently operated and is not owned by, affiliated with, or paid by any provider listed. We currently earn no commission and accept no payment for placement; all rankings are editorial and based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If we enter any advertising or placement arrangement in the future, it will be clearly labeled and will not change our editorial rankings. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →